HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 21 February 2018

New project: NICE topics

ScHARR-TAG has been allocated the following STA topics:

·         Moxetumomab pasudotox for hairy-cell leukaemia [ID1142]

·         Pembrolizumab for untreated gastric or gastro-oesophageal junction cancer [ID1305]

·         Clostridium botulinum neurotoxin type A for treating hypersalivation associated with neurological conditions [ID1150
Posted by at
Labels: ,